Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

Ovarian cancer, often termed a 'silent killer,' is frequently diagnosed late due to subtle, easily dismissed early symptoms ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

Inherited changes in the tumor suppressor genes BRCA1 and BRCA2, raise lifetime risk substantially. For ovarian cancer, the ...

Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

First-line PARP inhibitor maintenance after platinum chemotherapy reduces progression risk in certain patients with ovarian ...

Ovarian cancer and irritable bowel syndrome (IBS) can present with similar symptoms, making it challenging to distinguish between them. Both conditions may cause abdominal discomfort, bloating, and ...

Dr. Erin Stevens of Green Bay recently became the first physician in northeast Wisconsin to use Cytalux in an operation, ...

FZOCUS-1 assessed the safety and efficacy of fuzuloparib alone and in combination with apatinib for patients with newly diagnosed or advanced ovarian cancer.

The moment that we were told that they were raising this money, my wife and I got on our knees in our bedroom and we prayed,” ...